Immunotherapy of Tocilizumab for Rheumatoid Arthritis

Journal of Clinical & Cellular Immunology
doi 10.4172/2155-9899.s6-001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Longitudinal Immunomonitoring Following Tocilizumab in Rheumatoid Arthritis

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Tocilizumab, a Humanized Anti-Interleukin-6 Receptor Antibody, for Treatment of Rheumatoid Arthritis

Open Access Rheumatology: Research and Reviews
Rheumatology
2011English

FRI0248 Incidence of Melanoma in Patients With Rheumatoid Arthritis Treated With Tocilizumab

2017English

Dendritic Cell-Based Immunotherapy for Rheumatoid Arthritis: From Bench to Bedside

Immune Network
Infectious DiseasesImmunologyAllergy
2016English

Pms56 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Without Methotrexate in Rheumatoid Arthritis Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Acute Anterior Uveitis After Discontinuation of Tocilizumab in a Patient With Rheumatoid Arthritis

Clinical Ophthalmology
Ophthalmology
2014English

Pms44 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness Analysis of Tocilizumab Subcutaneouscombotherapy First Line for the Management of Rheumatoid Arthritis in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Dramatic Radiographic Repair by Tocilizumab in a Very Elderly Patient With Rheumatoid Arthritis

Modern Rheumatology
MedicineRheumatology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy